(CTN News) – During this temporary halt in sales, Apple will work on modifying the affected features on its Series 9 and Ultra 2 smartwatches to avoid any patent infringement.
The company is also exploring potential licensing agreements with Masimo to resolve the dispute and resume sales as soon as possible.
The blood oxygen feature, which measures the oxygen saturation level in a user’s blood, has become increasingly popular and relevant in the current health-conscious climate. It is a key selling point for Apple’s smartwatches, as it provides users with valuable health data and insights.
The patent dispute with Masimo raises concerns for Apple, as it not only affects the sales of its smartwatches but also poses a potential setback in terms of reputation and market share.
Apple has built a strong brand image around its innovative and cutting-edge technology, and any legal disputes can tarnish its reputation as a leader in the industry.
The outcome of the Presidential review period will determine the future of Apple’s smartwatch sales in the United States. If the ruling is upheld, Apple may have to pay significant damages to Masimo and potentially face further legal consequences.
This could also open the door for other companies to file similar patent infringement claims against Apple, leading to more disruptions in its product lineup.
In the meantime, Apple will continue to focus on its other product offerings and services to mitigate the impact of the sales halt.
The company has a diverse portfolio, including iPhones, iPads, Macs, and various software and subscription services, which can help offset any potential losses from the smartwatch sales suspension.
Overall, the decision to temporarily halt the sales of its Series 9 and Ultra 2 smartwatches in the United States reflects the company’s commitment to resolving the patent dispute and ensuring compliance with intellectual property rights.
It also highlights the challenges and risks that technology companies face in a highly competitive and litigious industry.